Farmadistri
0716.742.995 · rovalta.com · 24/09/2026
Farmadistri
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOFarmadistri is a Private limited company incorporated in 2018. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Oudenburg. It employs on average 2,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0716.742.995
- Incorporation
- 21/12/2018
- Legal form
- Private limited company
- Registered office
- Brugsesteenweg 5A
8460 Oudenburg · FlandreSee on map - Contributed capital
- 6 300,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,1 ETP
Joint committees (1)
- 321
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 701,2 k € | +11.3% | 629,8 k € | +115% | 293 k € | +21.4% | 241,3 k € | +72.7% | 139,7 k € |
| EBITDA | 603,4 k € | +16.4% | 518,6 k € | +88.8% | 274,7 k € | +14.4% | 240,2 k € | +72.6% | 139,1 k € |
| Operating result | 596,3 k € | +16.1% | 513,4 k € | +90.6% | 269,4 k € | +13.0% | 238,5 k € | +73.4% | 137,5 k € |
| Net result | 479,9 k € | +17.5% | 408,6 k € | +97.5% | 206,9 k € | +8.3% | 191 k € | +61.7% | 118,2 k € |
| Balance sheet | |||||||||
| Equity | 759,9 k € | +76.7% | 429,9 k € | +2.0% | 421,4 k € | +79.7% | 234,4 k € | +181% | 83,4 k € |
| Total assets | 1,6 M € | +12.6% | 1,4 M € | +74.3% | 810,4 k € | +43.2% | 565,8 k € | +141% | 234,8 k € |
| Cash | 35,4 k € | +886% | 3,6 k € | -98.0% | 180,7 k € | -26.3% | 245,3 k € | +111% | 116,3 k € |
| Debts | 830,4 k € | -14.5% | 971,3 k € | +150% | 388,6 k € | +17.4% | 331 k € | +119% | 151,4 k € |
| Other | |||||||||
| Workforce | 2,1 ETP | +5.0% | 2,0 ETP | +100% | 1,0 ETP | – | – | ||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20254 active · 12 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/07/2026 | 03/07/2025 | 08/07/2024 | 10/07/2023 | 09/08/2022 | 21/06/2021 |
| General meeting | 30/06/2026 | 26/03/2025 | 14/05/2024 | 09/05/2023 | 28/06/2022 | 10/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 14/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 26/03/2025 | 03/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 14/05/2024 | 08/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 09/05/2023 | 10/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 28/06/2022 | 09/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 10/05/2021 | 21/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 26/06/2020 | 07/09/2020 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20254 active · 12 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates24/02/2026ONTSLAGEN - BENOEMINGEN
- Mandates30/06/2025ONTSLAGEN - BENOEMINGEN
- Mandates17/05/2024ONTSLAGEN - BENOEMINGEN
- Mandates24/10/2023KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates20/01/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates20/01/2020ONTSLAGEN - BENOEMINGEN
- Other27/12/2018RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025479,9 k €↑
- 2024Annual accounts 2024408,6 k €↑
- 2023Annual accounts 2023206,9 k €↑
- 2022Annual accounts 2022191 k €↑
- 2021Annual accounts 2021118,2 k €↑
- 2020Annual accounts 202032,9 k €↑
- 2019Annual accounts 2019-8,3 k €
- 21/12/2018IncorporationPrivate limited company